Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Qube Research & Technologies (QRT)'s XBI Position: Q1 2026 in Review
Qube Research & Technologies (QRT) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 146% in Q1 2026, buying an estimated $14.1M and bringing the position to 190,717 shares worth $24.4M. The position accounts for 0.03% of the portfolio, ranked #770.
Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 17 quarters since. The position peaked at $28.6M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Qube Research & Technologies (QRT) held 190,717 shares of State Street SPDR S&P Biotech ETF worth $24.4M as of Q1 2026.
- Qube Research & Technologies (QRT) bought 113,217 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $14.1M.
- State Street SPDR S&P Biotech ETF made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #770 holding.
- Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 17 quarters since.
- Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.